.

follow-on-google-news

With stable growth and resilience, the healthcare sector provides the most lucrative investment opportunities. The Indian healthcare sector is projected to reach $638 billion by 2025, according to Bajaj Finserv AMC. It was valued at $110 billion in 2016; the Indian healthcare market reached $372 billion in 2023, with a CAGR growth of 22.5 percent during this period.

This article will show you the four best healthcare stocks to watch.

Max Healthcare Institute Ltd

Max Healthcare Institute Limited is primarily engaged in providing healthcare services through primary care clinics, multi-specialty hospitals / medical centers, and super-specialty hospitals providing operation and management, medical services, clinical, radiology, pathology services, and related healthcare services.

With a market cap of Rs 1,08,647 crores. It made a 52-week high of Rs 1,227.50 per share, down by 9 percent, from its CMP of Rs 1,118 per share. It has an ROE and ROCE of 13.37 percent and 16 percent respectively. Also, it has a PE of 102.46x, which is significantly higher than the industry PE of 52.37x.

Apollo Hospitals Enterprise Ltd.

Apollo Hospitals Enterprise Limited is a leading healthcare provider operating in India and internationally. It primarily offers specialty care, including cardiac sciences, orthopedics, oncology, neurology, and transplants. The company also provides health insurance, medical education, research, and digital health services via Apollo 24/7. It also operates pharmacies, diagnostic centers, specialty clinics, and home healthcare services. 

With a market cap of Rs 92,599 crores. It made a 52-week high of Rs 7,545.35 per share, down by 15 percent, from its CMP of Rs 6,450 per share It has an ROE and ROCE of 13.33 percent and 15.11 percent respectively. Also, it has a PE of 70.67x, which is significantly higher than the industry PE of 52.37x.

Fortis Healthcare Ltd.

Fortis Health Ltd. is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics, and daycare specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. 

The Company also controls its diagnostics business through its 57 percent-owned subsidiary SRL Limited. It is amongst the largest private diagnostics chains. It has a presence in over 600 cities and towns, with an established strength of 415 laboratories, 8,200 direct clients, and 1,400 Collection Centers. 

With a market cap of Rs 50,446 crores. It made a 52-week high of Rs 744.50 per share, down by 10 percent, from its CMP of Rs 666.85 per share It has an ROE and ROCE of 7.85 percent and 10.34 percent respectively. Also, it has a PE of 64.17x, which is higher than the industry PE of 52.37x.

Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Limited is engaged in medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, nursing homes, and other related activities. The company is also engaged in the health insurance business.

With a market cap of Rs 34,035 crores. It made a 52-week high of Rs 1,725 per share, down by 3 percent, from its CMP of Rs 1,669 per share It has an ROE and ROCE of 31.43 percent and 26.54 percent respectively. Also, it has a PE of 43.43x, which is lower than the industry PE of 52.37x.

Written by Satyajeet Mukherjee

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

×